Literature DB >> 6582296

B16 murine melanoma and aging: slower growth and longer survival in old mice.

W B Ershler, J A Stewart, M P Hacker, A L Moore, B H Tindle.   

Abstract

The growth characteristics and colonization potential of a transplantable melanoma administered to young (3 mo) and old (24 mo) C57BL/6 mice were investigated. After sc injection of B16-F10 melanoma cells, tumor growth was slower, and final tumor volume was less in the older mice. Furthermore, after iv injection of B16-F1 melanoma cells, the number of pulmonary colonies was also less, and the survival was greater in the older mice. These findings indicate an age advantage in this experimental tumor model that may be attributed to either physical or immunologic factors.

Entities:  

Mesh:

Year:  1984        PMID: 6582296     DOI: 10.1093/jnci/72.1.161

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

Review 1.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

2.  Hyaluronan in aged collagen matrix increases prostate epithelial cell proliferation.

Authors:  Mamatha Damodarasamy; Robert B Vernon; Christina K Chan; Stephen R Plymate; Thomas N Wight; May J Reed
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-15       Impact factor: 2.416

Review 3.  How ageing processes influence cancer.

Authors:  João Pedro de Magalhães
Journal:  Nat Rev Cancer       Date:  2013-05       Impact factor: 60.716

4.  Opposing influence of age on the growth and colony-forming ability of mouse melanoma B16 and mammary adenocarcinoma: correlation with natural killer activity.

Authors:  J Gabrilovac; M Radacić; M Osmak; M Boranić
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity.

Authors:  Catalina Lee-Chang; Monica Bodogai; Kanako Moritoh; Purevdorj B Olkhanud; Andrew C Chan; Michael Croft; Julie A Mattison; Peter Johannes Holst; Ronald E Gress; Luigi Ferrucci; Fran Hakim; Arya Biragyn
Journal:  Blood       Date:  2014-07-18       Impact factor: 22.113

6.  Different metastatic modes of malignant melanoma implanted in the ear of young and old mice.

Authors:  R Hirayama; K Sato; K Hirokawa; M P Chang; Y Mishima; T Makinodan
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Dicarbonyl-mediated protein modifications affect matrix metalloproteinase (MMP) activity.

Authors:  B Bartling; M Desole; R-E Silber; A Simm
Journal:  Z Gerontol Geriatr       Date:  2007-10       Impact factor: 1.281

8.  Age-related decrease of pulmonary metastasis of rat mammary carcinoma by activated natural resistance.

Authors:  N Takeichi; X B Li; J Hamada; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 9.  Two-Step Senescence-Focused Cancer Therapies.

Authors:  Cynthia J Sieben; Ines Sturmlechner; Bart van de Sluis; Jan M van Deursen
Journal:  Trends Cell Biol       Date:  2018-05-17       Impact factor: 20.808

10.  Lymphocyte-induced angiogenesis factor is produced by L3T4+ murine T lymphocytes, and its production declines with age.

Authors:  E J Hadar; W B Ershler; R A Kreisle; S P Ho; M J Volk; R G Klopp
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.